Varian gets FDA nod, CE Mark for HyperSight-equipped Halcyon and Ethos systems
The firm has also announced the first patient treatment with a Halcyon system equipped with HyperSight at Penn…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Feb 23
The firm has also announced the first patient treatment with a Halcyon system equipped with HyperSight at Penn…
25 Jan 23
Hospitals in the US can now use Etiometry’s IDO2 Index to quickly identify changes in the conditions of…
25 Jan 23
The extended VADER Pedicle System maintains its proven indication and versatility for open, MIS and cement-augmented surgical techniques…
20 Jan 23
The FDA’s initial approval for the cardiac radioablation trial has been given for 80 patients at 10 US…
18 Jan 23
The company's latest-generation Navitor device has some upgrades to improve patient care, including reducing or eliminating the risk…
12 Jan 23
With the latest approval, the Swiss medical technology firm will start its clinical trial for which the enrolment…
05 Jan 23
Newest Addition to Company’s Zoom Stroke Solution Provides an Additional Option for Achieving Intracranial Access to Treat Patients…
04 Jan 23
BresoDX1 is indicated for use in the diagnosis of moderate to severe sleep apnea in adults in an…
22 Dec 22
The AI.ME robotic system utilizes an advanced visualization system, machine vision, and Artificial Intelligence algorithms to target the…
20 Dec 22
The FDA clearance is backed by the results of a trial involving 68 women at four sites in…